Ramesh Ramachandran - 02 Jan 2026 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Reporting relationship: Chief Accounting Officer
Issuer ticker: OCGN
Reported as of: 02 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jan 2026, 17:20:14 UTC
Prior SEC filing: 06 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Ramesh Ramachandran by Shankar Musunuri, his attorney-in-fact

Key filing fact

Ramesh Ramachandran filed Form 4 for Ocugen, Inc. (OCGN) on 06 Jan 2026.

Key facts

This page summarizes Ramesh Ramachandran's Form 4 filing for Ocugen, Inc. (OCGN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jan 2026, 17:20.

Change

Previous filing in this sequence was filed on 06 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002043659 Primary reporting owner

Ramachandran Ramesh

Relationship: Chief Accounting Officer
Address: C/O OCUGEN, INC., 11 GREAT VALLEY PARKWAY, MALVERN
Signature: /s/ Ramesh Ramachandran by Shankar Musunuri, his attorney-in-fact
Signature date: 06 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OCGN transaction

Common Stock

Award

Transaction value: $0
Shares: +207,300
Change %: +11517%
Price: $0.000000
Shares after: 209,100
Date: 02 Jan 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OCGN transaction Derivative

Option (Right to Buy)

Award

Transaction value: $0
Shares: +310,950
Change %
Price: $0.000000
Shares after: 310,950
Date: 02 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 310,950
Exercise price: $1.38
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest annually in three equal installments commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.

Footnote F2

The option vests annually in equal installments over three years commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.